Skip to main content

Cardiomyopathies, Heart Failure, and Pregnancy

  • Chapter
  • First Online:
  • 1912 Accesses

Abstract

Women with cardiomyopathy are at risk for complications during and after pregnancy if they are unable to adapt to the hemodynamic changes of pregnancy. The hemodynamic challenges of pregnancy, labor, and delivery pose unique risks to this group of patients which can result in clinical decompensation with overt heart failure, arrhythmias, and even maternal death. A multidisciplinary approach and a controlled delivery are crucial to adequate management of patients with underlying heart disease. Preconception planning, proper counseling, and accurate risk assessment are essential and should be offered to women of childbearing age. In this chapter, the risk assessment of pregnancy in women with cardiomyopathy will be reviewed. In addition, the management of pregnant women with cardiomyopathies and heart failure will be discussed including consideration of issues at the time of labor and delivery.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Silversides CK, Colman JM. Physiologic changes in pregnancy. In: Oakley C, Warnes CA, editors. Heart disease in pregnancy. Malden: Blackwell Publishing; 2007. p. 173–85.

    Google Scholar 

  2. Weiss BM, von Segesser LK, Alon E, Seifert B, Turina MI. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996. Am J Obstet Gynecol. 1998;179(6 Pt 1):1643–53.

    Article  PubMed  CAS  Google Scholar 

  3. 7th report of the confidential enquiries into maternal deaths in the UK. London: Royal College of Obstetrics and Gynecology; 2007.

    Google Scholar 

  4. Roos-Hesselink JW, Duvekot JJ, Thorne SA. Pregnancy in high risk cardiac conditions. Heart. 2009;95(8):680–6.

    Article  PubMed  Google Scholar 

  5. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol. 2010;116(6):1302–9.

    Article  PubMed  Google Scholar 

  6. Main EK. Maternal mortality: new strategies for measurement and prevention. Curr Opin Obstet Gynecol. 2010;22(6):511–6.

    Article  PubMed  Google Scholar 

  7. Kuklina E, Callaghan W. Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995–2006. BJOG. 2011;118(3):345–52.

    Article  PubMed  Google Scholar 

  8. Roos-Hesselink JW, Ruys TP, Stein JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34:657–65.

    Article  PubMed  Google Scholar 

  9. Grewal J, Siu SC, Ross H, Mason J, Balint O, Sermer M, Colman J, Silversides C. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol. 2010;55:45–52.

    Article  Google Scholar 

  10. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006;368(9536):687–93.

    Article  PubMed  Google Scholar 

  11. Gleicher N, Elkayam U. Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev. 2009;8(5):384–7.

    Article  PubMed  CAS  Google Scholar 

  12. Elkayam U. Pregnancy and cardiovascular disease. In: Zipes DP, Libby P, Bonow RO, Braunwald U, editors. Braunwald’s heart disease. 7th ed. Philadelphia: Elsevier; 1965.

    Google Scholar 

  13. Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc Med. 2008;18(5):173–9.

    Article  PubMed  CAS  Google Scholar 

  14. Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767–78.

    Article  PubMed  Google Scholar 

  15. Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58(7):659–70.

    Article  PubMed  Google Scholar 

  16. Stergiopoulos K, Shiang E, Bench T. Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol. 2011;58(4):337–50.

    Article  PubMed  Google Scholar 

  17. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147–97.

    Article  PubMed  Google Scholar 

  18. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Developed in Collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(23):e1–121.

    Article  Google Scholar 

  19. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440–63.

    Article  PubMed  Google Scholar 

  20. Shime J, Mocarski EJ, Hastings D, Webb GD, McLaughlin PR. Congenital heart disease in pregnancy: short- and long-term implications. Am J Obstet Gynecol. 1987;156(2):313–22.

    Article  PubMed  CAS  Google Scholar 

  21. Lui GK, Silversides CK, Khairy P, et al. Heart rate response during exercise and pregnancy outcome in women with congenital heart disease. Circulation. 2011;123(3):242–8.

    Article  PubMed  Google Scholar 

  22. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49(24):2303–11.

    Article  PubMed  Google Scholar 

  23. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–21.

    Article  PubMed  CAS  Google Scholar 

  24. Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124–32.

    Article  PubMed  Google Scholar 

  25. Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation. 2002;105(18):2179–84.

    Article  PubMed  Google Scholar 

  26. Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation. 1997;96(9):2789–94.

    Article  PubMed  CAS  Google Scholar 

  27. Howlett JG, McKelvie RS, Costigan J, et al. The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Can J Cardiol. 2010;26(4):185–202.

    Article  PubMed  Google Scholar 

  28. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92(10):1520–5.

    Article  PubMed  Google Scholar 

  29. Elkayam U, Ostrzega E, Shotan A, Mehra A. Cardiovascular problems in pregnant women with the Marfan syndrome. Ann Intern Med. 1995;123(2):117–22.

    Article  PubMed  CAS  Google Scholar 

  30. Vasu S, Stergiopoulos K. Valvular heart disease in pregnancy. Hellenic J Cardiol. 2009;50(6):498–510.

    PubMed  Google Scholar 

  31. Kovacs AH, Harrison JL, Colman JM, Sermer M, Siu SC, Silversides CK. Pregnancy and contraception in congenital heart disease: what women are not told. J Am Coll Cardiol. 2008;52(7):577–8.

    Article  PubMed  Google Scholar 

  32. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105(20):2392–7.

    Article  PubMed  Google Scholar 

  33. Tanous D, Siu SC, Mason J, et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol. 2010;56(15):1247–53.

    Article  PubMed  CAS  Google Scholar 

  34. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077–84.

    Article  PubMed  CAS  Google Scholar 

  35. Krul SP, van der Smagt JJ, van den Berg MP, Sollie KM, Pieper PG, van Spaendonck-Zwarts KY. Systematic review of pregnancy in women with inherited cardiomyopathies. Eur J Heart Fail. 2011;13(6):584–94.

    Article  PubMed  Google Scholar 

  36. Suri V, Aggarwal N, Kalpdev A, Chopra S, Sikka P, Vijayvergia R. Pregnancy with dilated and peripartum cardiomyopathy: maternal and fetal outcome. Arch Gynecol Obstet. 2013;287:195–9.

    Article  PubMed  Google Scholar 

  37. Katsuragi S, Omoto A, Kamiya C, et al. Risk factors for maternal outcome in pregnancy complicated with dilated cardiomyopathy. J Perinatol. 2012;32(3):170–5.

    Article  PubMed  CAS  Google Scholar 

  38. van den Berg MP, van Spaendonck-Zwarts KY, van Veldhuisen DJ. Dilated cardiomyopathy complicates pregnancy outcome: but how? J Am Coll Cardiol. 2010;55(20):2291; author reply 2291–2.

    Article  PubMed  Google Scholar 

  39. Kitao K, Ohara N, Funakoshi T, et al. Noncompaction of the left ventricular myocardium diagnosed in pregnant woman and neonate. J Perinat Med. 2004;32(6):527–31.

    Article  PubMed  Google Scholar 

  40. Jayan P, Shankarappa RK, Ananthakrishna R, Nanjappa MC. Isolated left ventricular noncompaction mimicking ventricular mass. Echocardiography. 2011;28(7):E137–9.

    Article  PubMed  Google Scholar 

  41. Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol. 2007;188(6):1447–74.

    Article  PubMed  Google Scholar 

  42. Greutmann M, Mah ML, Silversides CK, et al. Predictors of adverse outcome in adolescents and adults with isolated left ventricular noncompaction. Am J Cardiol. 2012;109(2):276–81.

    Article  PubMed  Google Scholar 

  43. Lofiego C, Biagini E, Pasquale F, et al. Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart. 2007;93(1):65–71.

    Article  PubMed  CAS  Google Scholar 

  44. Patel C, Shirali G, Pereira N. Left ventricular noncompaction mimicking peripartum cardiomyopathy. J Am Soc Echocardiogr. 2007;20(8):1009.e9–12.

    Article  Google Scholar 

  45. Rehfeldt KH, Pulido JN, Mauermann WJ, Click RL. Left ventricular hypertrabeculation/noncompaction in a patient with peripartum cardiomyopathy. Int J Cardiol. 2010;139(2):e18–20.

    Article  PubMed  Google Scholar 

  46. Williams RI, Masani ND, Buchalter MB, Fraser AG. Abnormal myocardial strain rate in noncompaction of the left ventricle. J Am Soc Echocardiogr. 2003;16(3):293–6.

    Article  PubMed  Google Scholar 

  47. Bahl A, Swamy A, Sharma Y, Kumar N. Isolated noncompaction of left ventricle presenting as peripartum cardiomyopathy. Int J Cardiol. 2006;109(3):422–3.

    Article  PubMed  Google Scholar 

  48. Agmon Y, Connolly HM, Olson LJ, Khandheria BK, Seward JB. Noncompaction of the ventricular myocardium. J Am Soc Echocardiogr. 1999;12(10):859–63.

    Article  PubMed  CAS  Google Scholar 

  49. Vainrib A, Stergiopoulos K. Hypertrophic cardiomyopathy and pregnancy. Minerva Ginecol. 2012;64(5):399–407.

    PubMed  CAS  Google Scholar 

  50. Thaman R, Varnava A, Hamid MS, et al. Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart. 2003;89(7):752–6.

    Article  PubMed  CAS  Google Scholar 

  51. Autore C, Conte MR, Piccininno M, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40(10):1864–9.

    Article  PubMed  Google Scholar 

  52. Alegria J, Nishimura RA. Hypertrophic cardiomyopathy and pregnancy. In: Oakley C, Warnes CA, editors. Heart disease in pregnancy. Malden: Blackwell Publishing; 2007. p. 173–85.

    Chapter  Google Scholar 

  53. Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med. 2001;344(21):1567–71.

    Article  PubMed  CAS  Google Scholar 

  54. Habli M, O’Brien T, Nowack E, Khoury S, Barton JR, Sibai B. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol. 2008;199(4):415.e1–5.

    Article  Google Scholar 

  55. Ross LF. Ethical considerations related to pregnancy in transplant recipients. N Engl J Med. 2006;354(12):1313–6.

    Article  PubMed  CAS  Google Scholar 

  56. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2004:103–14.

    Google Scholar 

  57. Scott JR, Wagoner LE, Olsen SL, Taylor DO, Renlund DG. Pregnancy in heart transplant recipients: management and outcome. Obstet Gynecol. 1993;82(3):324–7.

    PubMed  CAS  Google Scholar 

  58. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116(15):1736–54.

    Article  PubMed  Google Scholar 

  59. Silversides CK, Harris L, Haberer K, Sermer M, Colman JM, Siu SC. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol. 2006;97(8):1206–12.

    Article  PubMed  Google Scholar 

  60. Kockova R, Kocka V, Kiernan T, Fahy GJ. Ibutilide-induced cardioversion of atrial fibrillation during pregnancy. J Cardiovasc Electrophysiol. 2007;18(5):545–7.

    Article  PubMed  Google Scholar 

  61. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol. 2006;48(4):854–906.

    Article  PubMed  Google Scholar 

  62. Elkayam U, Singh H, Irani A, Akhter MW. Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther. 2004;9(2):107–15.

    Article  PubMed  CAS  Google Scholar 

  63. Robertson JE, Silversides CK, Mah ML, et al. A contemporary approach to the obstetric management of women with heart disease. J Obstet Gynaecol Can. 2012;34(9):812–9.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kathleen Stergiopoulos MD, PhD, FASE, FACC, FAHA .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Stergiopoulos, K. (2014). Cardiomyopathies, Heart Failure, and Pregnancy. In: Stergiopoulos, K., Brown, D. (eds) Evidence-Based Cardiology Consult. Springer, London. https://doi.org/10.1007/978-1-4471-4441-0_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4441-0_31

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4440-3

  • Online ISBN: 978-1-4471-4441-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics